PHVS Similar Chart Price Prediction
The price of PHVS is predicted to go up -22.82%, based on the high correlation periods with RIVN. The similarity of these two price pattern on the periods is 97.03%.
PHVS
RIVN
Down: -22.82%Similarity: 97.03%
PHVS Revenue Forecast
PHVS EPS Forecast
PHVS FAQs
What is PHVS eps forecast for next quarter？
PHVS Analyst's Forecast
Jonathan Wolleben
JMP Securities
Buy
2025-01-31
Price Target
$46 → $55
Upside
+212.5%
JMP Securities analyst Jonathan Wolleben raised the firm's price target on Pharvaris to $55 from $46 and keeps an Outperform rating on the shares. Pharvaris is the only company with an oral candidate for hereditary angioedema prophylaxis and on demand treatment, the analyst tells investors. Additionally, the company's extended release version of deucrictibant will be poised to be take prophylactic market share if its Phase 3 replicates the impressive Phase 2 data, JMP says.
Debanjana Chatterjee
Jones Trading
Strong Buy
2024-09-19
Price Target
$46
Upside
+118.11%
